Changes of adipocytokine expression after diabetic rats received sitagliptin and the molecular mechanism

Asian Pacific Journal of Tropical Medicine

Volumn 9, Issue 9, 2016, Pages 893-897

  Wu, Qiao Min ^a   Ni, Hai Xiang ^a   Lu, Xiao ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Adipocytokines; Diabetes mellitus; Phosphatidylcholine 3 kinase; Sitagliptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; CHEMERIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; SITAGLIPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAPERITONEAL FAT; MALE; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84992709819     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtm.2016.07.014     Document Type: Article

References (22)

1. [1] Adamiak, P., Łącka, K., Adipose tissue, adipokines and aging. Pol Merkur Lek 40:236 (2016), 122-128.
2. [2] Mansur, R.B., Rizzo, L.B., Santos, C.M., Asevedo, E., Cunha, G.R., Noto, M.N., et al. Adipokines, metabolic dysfunction and illness course in bipolar disorder. J Psychiatr Res 74 (2016), 63-79.
3. [3] Bjornstad, P., Truong, U., Dorosz, J.L., Cree-Green, M., Baumgartner, A., Coe, G., et al. Cardiopulmonary dysfunction and adiponectin in adolescents with type 2 diabetes. J Am Heart Assoc, 4(3), 2016, e002804.
4. [4] Barbarash, O., Gruzdeva, O., Uchasova, E., Dyleva, Y., Belik, E., Akbasheva, O., et al. The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction. Diabetol Metab Syndr, 17(8), 2016, 24.
5. [5] Olarescu, N.C., Bollerslev, J., The impact of adipose tissue on insulin resistance in acromegaly. Trends Endocrinol Metab 27:4 (2016), 226-237.
6. [6] Wu, W.L., Hao, J., Domalski, M., Burnett, D.A., Pissarnitski, D., Zhao, Z., et al. Discovery of novel tricyclic heterocycles as potent and selective DPP-4 inhibitors for the treatment of type 2 diabetes. ACS Med Chem Lett 7:5 (2016), 498-501.
7. [7] Bonora, E., Cigolini, M., DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives. Nutr Metab Cardiovasc Dis 26:4 (2016), 273-284.
8. [8] Linnemann, A.K., Davis, D.B., Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity. J Diabetes Investig 7:Suppl 1 (2016), 44-49.
9. [9] Araújo, F., Shrestha, N., Gomes, M.J., Herranz-Blanco, B., Liu, D., Hirvonen, J.J., et al. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy. Nanoscale 8:20 (2016), 10706-10713.
10. [10] Fukui, K., Kawahito, H., Wakana, N., Kikai, M., Terada, K., Yamamoto, K., et al. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers. J Renin Angiotensin Aldosterone Syst 16:4 (2015), 1001-1009.
11. [11] Umezawa, S., Kubota, A., Maeda, H., Kanamori, A., Matoba, K., Jin, Y., et al. Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: post hoc analysis of the ASSET-K study. BMC Endocr Disord, 3(15), 2015, 34.
12. [12] Fang, L., Guo, F., Zhou, L., Stahl, R., Grams, J., The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte 4:4 (2015), 273-279.
13. [13] Taira, S., Shimabukuro, M., Higa, M., Yabiku, K., Kozuka, C., Ueda, R., et al. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome. Intern Med 52:14 (2013), 1561-1571.
14. [14] Wang, Z., Zeng, X., Chen, Z., Wang, X., Zhang, L., Zhu, M., et al. Association of visceral and total body fat with hypertension and prehypertension in a middle-aged Chinese population. J Hypertens 33:8 (2015), 1555-1562.
15. [15] Boulet, M.M., Chevrier, G., Grenier-Larouche, T., Pelletier, M., Nadeau, M., Scarpa, J., et al. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. Am J Physiol Endocrinol Metab 309:8 (2015), 736-746.
16. [16] Yanai, H., Hirowatari, Y., Different associations of body mass index and visceral fat area with metabolic parameters and adipokines in Japanese patients with type 2 diabetes. Diabetes Metab 41:3 (2015), 261-262.
17. [17] Eslamian, M., Mohammadinejad, P., Aryan, Z., Nakhjavani, M., Esteghamati, A., Positive correlation of serum adiponectin with lipid profile in patients with type 2 diabetes mellitus is affected by metabolic syndrome status. Arch Iran Med 19:4 (2016), 269-274.
18. [18] Zhang, Q., Zhu, L., Zheng, M., Fan, C., Li, Y., Zhang, D., et al. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults. Ann Endocrinol (Paris) 75:3 (2014), 171-175.
19. [19] Ayina, C.N., Noubiap, J.J., Etoundi Ngoa, L.S., Boudou, P., Gautier, J.F., Mengnjo, M.K., et al. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population. Lipids Health Dis, 15(1), 2016, 96.
20. [20] Li, Y., Shi, B., Li, S., Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis. PLoS One, 9(12), 2014, e113915.
21. [21] Mishra, J., Verma, R.K., Alpini, G., Meng, F., Kumar, N., Role of Janus kinase 3 in predisposition to obesity-associated metabolic syndrome. J Biol Chem 290:49 (2015), 29301-29312.
22. [22] Li, S., Chen, H., Wang, J., Wang, X., Hu, B., Lv, F., Involvement of the PI3K/Akt signal pathway in the hypoglycemic effects of tea polysaccharides on diabetic mice. Int J Biol Macromol 81 (2015), 967-974.